Introduction
============

Yeast cells are exposed to strongly fluctuating nutrient concentrations in their environment, which requires rapid and efficient adaptation through rearrangements on all levels of their metabolism. These rearrangements serve to ensure energy supply from different carbon sources, they enable tight coordination of metabolic processes that provide and consume energy, and ultimately facilitate growth or survival. The quantitative understanding of these adaptation processes represents the basis for a directed optimization of the microorganism to suit the needs of biochemical production processes that often impose non-uniform or harsh cultivation conditions ([@b39]), or require a redirection of metabolic fluxes to improve productivity ([@b3]).

In this context, controlled perturbation experiments represent a valuable tool, as they allow studying the transition from one defined physiological state to another under well-characterized conditions. Examples for investigations of such type are experiments in which yeast cultures are exposed to sudden changes in nutrient concentration ([@b70]), oxygen supply ([@b67]), the administration of electron acceptors other than oxygen ([@b45]), or metabolic uncouplers ([@b38]), respectively, to investigate the metabolic response. Measurements of metabolite pool dynamics and enzymatic activities in response to different perturbations enable the quantitative mathematical analysis of glycolytic dynamics, which is ultimately meant to discriminate the impact of allosteric regulation and changes in the enzymatic make-up of the cell on the overall metabolic response ([@b54]; [@b59]; [@b13]; [@b67]).

Owing to its economic role as the most important ethanol producer, the transition from respiratory to fermentative growth of *Saccharomyces cerevisiae* received particularly strong attention. After the pioneering work of [@b62] and the optimization of sampling and analytical techniques in recent years ([@b71]; [@b45]; [@b44]; [@b9]), it is now well established that the immediate response of the cell\'s metabolism implies strong changes in glycolytic metabolite and cofactor levels, which manifest within few seconds after glucose addition. The presence of glucose and the changes in intracellular metabolite levels activate signaling cascades ([@b63]), among which the cAMP protein kinase A (PKA) pathway has the predominant role in controlling the respiro-fermentative transition ([@b47]; [@b55]; [@b72]; [@b78]). The activation of PKA triggers posttranslational modification of enzymes involved in gluconeogenesis ([@b46]), glycolysis ([@b20]) and storage of carbohydrates ([@b19]), and eventually controls the transcriptional downregulation of respiratory and gluconeogenetic pathways ([@b63]; [@b78]).

A long standing problem in the context of these studies is the apparent loss of adenine nucleotides, which immediately follows the relief from glucose limitation ([@b61]; [@b37]). Given the fact that adenine nucleotides are important regulators of several glycolytic enzymes, the unknown fate of AXPs must compromise the mathematical investigation of dynamic metabolic interactions ([@b59]; [@b5]; [@b51]). In addition, metabolic rearrangements on changing environmental conditions serve to ensure the equilibrium between energy supply and demand to prevent the catastrophic loss of energy that may cause substrate accelerated death ([@b64]; [@b60]; [@b21]). Thus, the fact that the fate of apparently lost adenine nucleotides is still unclear points to a significant lack in our understanding of mechanisms that rule the respiro-fermentative transition in yeast. Consequently, the search for the destination of AXP nucleotides, and the functional role and regulation of their removal has attained strong attention in recent studies ([@b70]; [@b37]), without, however, identifying the pathway(s) implied in AXP homeostasis.

In this study, we showed that the transient accumulation of the purine salvage pathway (PSP) metabolites, IMP and inosine, accounted for the apparent loss of AXP nucleotides. We identified the pathway for inosine accumulation and recycling, and demonstrated that inosine formation is a specific response to perturbations of energy homeostasis under fermentative conditions. In the absence of fermentable sugars, perturbation of energy homeostasis rather resulted in the formation of AMP and no inosine was formed. The impact of defective AXP cycling on the global metabolic response to glucose addition was tested under conditions in which respiration was inhibited by antimycin A: in the *amd1* mutant, in which adenine nucleotide cycling was completely blocked, adenylic energy charge exhibited a strong drop after glucose addition, and recovered much slower than in wild-type cells. Furthermore, deletion of *AMD1* resulted in strong accumulation of AMP and pronounced changes in the dynamics of several metabolite pools after glucose addition. Although PSP mutants did not exhibit any growth phenotype under constant cultivation conditions, the *amd1* and *isn1* mutant strains showed delayed growth acceleration after glucose addition. Differences in growth dynamics were not accompanied by changes in the formation of the fermentative end products: ethanol and glycerol.

Results
=======

Shake flask cultivation on trehalose mimics glucose-limited growth and can be used for metabolic analyses after glucose upshift
-------------------------------------------------------------------------------------------------------------------------------

Analysis of the respiro-fermentative transition is classically carried out with yeast cells cultivated in chemostat at low dilution rate, resulting in a constant growth rate and fully respiratory growth. However, this cultivation mode requires comparatively sophisticated instrumentation and is, thus, less suitable for high throughput studies using a large collection of mutants. In a recent study, we showed that the yeast *S. cerevisiae* cultivated on trehalose grew at a constant growth rate of 0.045 h^−1^, which is well below 0.1 h^−1^ commonly set in chemostat experiments. This constant growth rate resulted from the rate-limiting cleavage of the disaccharide trehalose into two glucose molecules by the periplasmic acid trehalase encoded by *ATH1* ([@b31]). Consequently, the metabolic regimen was strictly respiratory, with no fermentative end products, ethanol and glycerol, detected. In this study, we used the fact that glucose-limited growth can be conveniently mimicked by shake flask cultivations using trehalose as the limiting carbon source ([@b30]).

[Figure 1](#f1){ref-type="fig"} shows typical profiles of intracellular metabolite pools in response to the addition of glucose to wild-type cells growing on trehalose. Immediately after the relief from glucose limitation, the phosphorylated sugars: glucose-6-phosphate (G6P), trehalose-6-phosphate (T6P), glucose-1-phosphate (G1P), and fructose-1,6-bisphosphate (F1,6P) exhibited a strong increase ([Figure 1E, F and I](#f1){ref-type="fig"}). High F1,6P levels were maintained in the presence of excess glucose, which is consistent with its positive effect on the yeast\'s fermentation capacity brought about by the activation of pyruvate kinase. In contrast, G6P, F6P, G1P accumulated only transiently and decreased to their initial levels within few minutes. Similar to what was first observed by [@b28], T6P concentration passed through a maximum of ∼9 μmol/g DW, which was 30 times higher than before glucose administration, and stabilized at a concentration of ∼0.5 μmol/g DW after 30 min, which was only 2--3 times higher than under fully respiratory conditions. Metabolites in the lower part of glycolysis ([Figure 1L](#f1){ref-type="fig"}), that is, 1,3-phosphoglycerate (1,3-diPglyc), 2-phosphoglycerate and 3-phosphoglycerate (measured as a single pool denoted 2/3-Pglyc), as well as phosphoenolpyruvate (PEP), exhibited the characteristic decrease reported earlier ([@b24]; [@b70]). In agreement with previous studies ([@b61]; [@b37]), a pronounced transient drop of adenine (AXP) nucleotide concentrations was observed ([Figure 1C](#f1){ref-type="fig"}), which was caused by the decrease of ATP ([Figure 1A](#f1){ref-type="fig"}). Changes in the AXP balance were accompanied by a transient decrease in the adenylic energy charge (e-charge=(\[ATP\]+0.5\[ADP\])/(\[ATP\]+\[ADP\]+\[AMP\]) ([@b12])). Similarly, GXP nucleotide concentration exhibited a slight decrease immediately after glucose addition ([Figure 1C](#f1){ref-type="fig"}). However, although the AXP concentration quickly recovered to about 80% of its initial level, the GXP concentration reached a new steady state that was significantly higher than that before glucose addition. Finally, we report an increase in the concentrations of the pentose phosphate pathway (PPP) metabolites: 6-phosphogluconate (6PG), ribose-1-phosphate (R1P), and the ribose-5-phosphate/ribulose-5-phosphate pool (measured as a single pool denoted R5P), which was accompanied by a significant augmentation in the concentration of the purine nucleotide precursor PRPP ([Figure 1H and J](#f1){ref-type="fig"}). Altogether, the intracellular metabolite pool dynamics in trehalose-grown cells exposed to glucose addition were in good agreement with earlier studies that were exclusively carried out in chemostat cultivations ([@b61]; [@b68]; [@b70]; [@b37]). Therefore, we conclude that transitory phenomena observed during the shift from glucose limitation to glucose excess can be conveniently studied in our comparatively simple experimental set-up.

IMP and inosine are the major sinks for adenine nucleotides
-----------------------------------------------------------

The fact that the decrease of the AXP concentration was not counterbalanced by an increase in the other purine and pyrimidine nucleotide pools (([@b37]), also see [Figure 1C](#f1){ref-type="fig"}) led us to investigate the behavior of PSP metabolites after glucose addition ([@b44]). Our analyses revealed that only IMP and inosine responded significantly to glucose addition. As can be seen in [Figure 2](#f2){ref-type="fig"}, IMP and inosine concentration increased transiently after glucose administration, with IMP being detected only within the first ∼2 min, and inosine being detectable in the cells for at least 10 min. The sum of AXP, IMP, inosine, and hypoxanthine did not decrease after the glucose pulse, therefore, indicating that accumulation of IMP and inosine fully account for the apparent loss of adenine nucleotides commonly observed under these conditions.

Inosine formation is a specific response to perturbations of the AXP balance that requires the presence of a fermentable carbon source or a sugar derivative that undergoes phosphorylation by hexokinase
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

We next set out to investigate which factors cause the accumulation of inosine and exposed respiring yeast cells to different carbon sources. [Table I](#tI){ref-type="table"} summarizes the results of these experiments. Fermentable sugars, addition of which provoked a drop in ATP level similar to glucose, induced formation of inosine. Furthermore, the administration of 2-deoxyglucose, a sugar derivative that can only undergo the first glycolytic phosphorylation step by hexokinase, caused a drop in ATP level and formation of inosine ([Figure 3A--C](#f3){ref-type="fig"}). Administration of 6-deoxyglucose that is not phosphorylated and does not provoke changes in the AXP balance did not suffice to induce accumulation of inosine ([Figure 3D--E](#f3){ref-type="fig"}). Similarly, when glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was rapidly inactivated by the addition of hydrogen peroxide ([@b23]) to the cultivation medium of fermenting cells, inosine accumulated in response to the resulting drop in ATP concentration ([Figure 3G--I](#f3){ref-type="fig"}). When GAPDH was inactivated in respiring cells, AXP levels remained constant and no inosine was formed ([Figure 3J--L](#f3){ref-type="fig"}; inactivation of GAPDH under both fermentative and respiratory conditions was verified experimentally; data not shown). When intracellular ATP concentrations were caused to drop in the absence of a fermentable carbon source, for example, by addition of the mitochondrial inhibitor, antimycin A, to respiring cells ([Figure 3M--O](#f3){ref-type="fig"}), or by rapidly depriving fermenting cells from glucose ([Figure 3P--R](#f3){ref-type="fig"}), inosine was not formed but AMP accumulated instead. Therefore, we conclude that inosine formation is a specific response to perturbations of the AXP balance that requires the presence of a fermentable carbon source or a sugar derivative that undergoes rapid phosphorylation by hexokinase.

Identification of the pathway for inosine accumulation and recycling
--------------------------------------------------------------------

In subsequent experiments, the metabolic pathway for inosine formation and recycling was identified. [Figure 4](#f4){ref-type="fig"} depicts a schematic representation of the purine salvage pathway to show metabolic reactions that are potentially involved in this process. Not all PSP reactions that were identified according to the KEGG database ([@b32]) have a known representation in *S. cerevisiae.* [Figure 4](#f4){ref-type="fig"} accounts for these uncertainties by plotting potentially relevant (but in yeast still unknown) reactions as dashed lines. To identify the reactions responsible for AXP cycling, different PSP mutants were cultivated on trehalose medium, exposed to an increase in glucose concentration, and sampled for intracellular metabolites. Results of these experiments are summarized in [Figure 5](#f5a){ref-type="fig"}. The first step of the AXP-to-inosine conversion is catalyzed by AMP deaminase, encoded by *AMD1* ([@b49]), which transforms AMP into IMP ([Figure 4](#f4){ref-type="fig"}). Glucose addition to the *amd1* mutant caused a transient drop in ATP level, which was accompanied by an equimolar increase in AMP, whereas no detectable amounts of IMP or inosine were formed ([Figure 5A--C](#f5a){ref-type="fig"}). The sum of AXP nucleotides even exhibited a transient increase contrary to the drop observed in wild-type cells. Whether or not this transient increase was caused by a rapid response of the AXP *de novo* synthesis pathway or by transiently draining a neighboring metabolite pool into AXP could not be answered by our analyses. The deletion of *AMD1* was the only mutation that resulted in the accumulation of AMP after glucose addition ([Figure 5](#f5a){ref-type="fig"}). The IMP-specific 5′-nucleotidase, encoded by *ISN1* ([@b29]), is the only enzyme that catalyses the conversion of IMP into inosine, as proven by the complete block of inosine formation in the *isn1* mutant and the pronounced accumulation of IMP ([Figure 5D--F](#f5a){ref-type="fig"}). Recycling of inosine is facilitated by the purine nucleoside phosphorylase, encoded by *PNP1* ([@b43]), which converts inosine into hypoxanthine. In the *pnp1* strain, inosine levels remained constantly elevated for more than 30 min after glucose addition ([Figure 5G--I](#f5a){ref-type="fig"}). Under these conditions, replenishment of the AXP pool and recovery of the initial ATP concentration took considerably longer than in the wild-type strain. The conversion of hypoxanthine to IMP is facilitated by the phosphoribosyltransferase, encoded by *HPT1* ([@b75]). Unexpectedly, hypoxanthine did not accumulate in the *hpt*1 mutant, but inosine recycling was significantly slowed down ([Figure 5J--L](#f5a){ref-type="fig"}). The deletion of another phosphoribosyltransferase, encoded by *XPT1*, which is known to catalyze the conversion of xanthine into XMP and to rescue *hpt1* phenotypes when overexpressed ([@b25]), did not have any effect on the rate of inosine recycling (data not shown). In an attempt to completely abolish inosine recycling, an *hpt1 xpt1* double mutant was produced and exposed to sudden glucose addition. Curiously, the double mutant *hpt1 xpt1* exhibited a smaller drop in ATP level after glucose addition, and consequently accumulated much less inosine ([Figure 5M--O](#f5a){ref-type="fig"}). Contrary to the single phosphoribosyltransferase mutants, inosine was detectable even 60 min after the glucose pulse (60 min time point not shown). However, both single and double phosphoribosyltransferase mutants could not completely block the disappearance of inosine from the cells, which indicates the presence of yet another metabolic route for inosine degradation.

The contribution of the purine nucleotide *de novo* synthesis to the kinetics of AXP recovery was investigated using an *ade5,7* mutant. As this strain was purine base auxotroph, cells were grown in the presence of 0.1 g/l adenine, washed and resuspended in the standard cultivation medium without adenine 1 h before the relief from glucose limitation. We found that inosine formation was not affected in the *ade5,7* mutant. However, inosine degradation was slowed down and resulted only in a partial (but significant) recovery of AXP levels ([Figure 5P--R](#f5b){ref-type="fig"}).

Transformation of IMP into AMP requires the subsequent action of adenylosuccinate synthase and adenylosuccinate lyase, encoded by *ADE12* and *ADE13*, respectively ([Figure 4](#f4){ref-type="fig"}). The impact of mutations that prevent the conversion of IMP into AMP on AXP and purine nucleotide levels after glucose addition was tested by using an *ade12* strain using the same experimental procedures as used for the *ade5,7* mutant. The decrease in AXP nucleotides after glucose addition could not be compensated in *ade12* ([Figure 5S--U](#f5b){ref-type="fig"}), proving that inosine recycling and/or purine nucleotide *de novo* synthesis are the only pathways that significantly contribute to the regulation of the AXP pool size. Inosine was detectable in the cells over the whole observed time span of 60 min, but continuously decreased without causing an increase in neither hypoxanthine, IMP, nor GXP (data not shown) concentration.

Finally, the contribution of adenylate kinase, encoded by *ADK1* ([@b65]), to AXP homeostasis was tested. When cultivated on trehalose, *adk1* cells exhibited the same AXP concentrations as the wild-type cells, indicating that the UMP kinase, encoded by *URA6* ([@b56]), can compensate for the lack of Adk1 under these conditions. However, after glucose addition initial ATP concentrations were not reestablished and inosine concentration remained elevated for up to 60 min (60 min time point not shown). Similar to the situation in the *ade5,7*, *hpt1 xpt1*, and *ade12* mutants, the decrease in inosine concentration did not result in the replenishment of the AXP pool. In contrast, an overall drop in purine nucleotide and nucleoside concentrations was observed. Furthermore, the *adk1* mutant was the only tested strain incapable to reestablish its adenylic energy charge (e-charge) to the level before glucose addition ([Supplementary Figure S1](#S1){ref-type="supplementary-material"}). In the course of our investigation, we additionally tested strains with deletions in *ADO1*, *YNK1*, and *AAH1* and found that these mutations did not have any significant impact on the kinetics of inosine formation or recycling (data not shown).

Inhibition of respiration affected recovery of AXP nucleotides and altered glycolytic metabolite pool dynamics in the *amd1* mutant on glucose addition
-------------------------------------------------------------------------------------------------------------------------------------------------------

As adenine nucleotides are potent regulators of several glycolytic enzymes (e.g. [@b79]; [@b59]), we asked whether abolishment of inosine formation or recycling, respectively, causes significant differences in the intracellular metabolite pool kinetics of glycolysis, PPP, and PSP during the respiro-fermentative transition. When respiring yeast cells undergo transition to fermentative growth, both glycolytic substrate level phosphorylation and mitochondrial ATP production contribute to the regeneration of ATP levels after glucose addition ([@b52]). Thus, a potential deregulation of glycolysis due to impaired conversion of adenine nucleotides into inosine might be partially compensated by mitochondrial activity. Therefore, we investigated the behavior of PSP mutants during relief from glucose limitation when respiration was blocked by the presence of antimycin A (in control experiments it was verified that incubation with antimycin A alone did not cause inosine formation (compare to [Figure 3M--O](#f3){ref-type="fig"})). We measured 24 intracellular metabolites in the wild-type, *amd1*, *isn1*, and *pnp1* strains in response to glucose addition in the presence of antimycin A. A color-coded representation was chosen to highlight changes between different mutants and conditions ([Figure 6](#f6){ref-type="fig"}). In addition, graphs showing the metabolite concentrations individually are provided in [Supplementary Figures S2--S6](#S1){ref-type="supplementary-material"}. Inosine recycling and ATP regeneration were significantly slowed down in the wild-type strain (compare [Figures 6](#f6){ref-type="fig"}, [2A, B](#f2){ref-type="fig"} and [Supplementary Figure S2](#S1){ref-type="supplementary-material"}), indicating that mitochondrial function contributed significantly to the comparatively fast recovery of ATP levels when antimycin A was absent. Similarly, elevated AMP and IMP concentrations were significantly longer detectable in the *amd1* and *isn1* mutant strains, respectively ([Figures 5](#f5a){ref-type="fig"}, [6](#f6){ref-type="fig"} and [Supplementary Figure S2](#S1){ref-type="supplementary-material"}). In the absence of antimycin A, ATP concentration in all strains recovered to almost the same level as before glucose addition, whereas presence of this respiratory inhibitor caused the ATP concentration to reach only ∼65% of its initial value ([Figures 5](#f5a){ref-type="fig"}, [6](#f6){ref-type="fig"} and [Supplementary Figure S2](#S1){ref-type="supplementary-material"}). As shown in [Figure 7](#f7){ref-type="fig"}, e-charge dropped to lower levels and recovered much slower in the *amd1* mutant than in the wild-type strain and the other tested PSP mutant strains.

The kinetics of intracellular metabolite concentrations in response to glucose were significantly altered in the wild-type when mitochondrial function was impeded by the presence of the inhibitor antimycin A ([Figure 6](#f6){ref-type="fig"}). When cells were treated with antimycin A before glucose addition, the phosphorylated sugars: G1P, G6P and F6P exhibited a less pronounced peak. Furthermore, individual guanosine nucleotide (GTP, GDP, and GMP) concentrations and their sum (GXP) did not show the significant increase after glucose addition, as observed in the absence of antimycin A. Similarly, 6PG, R5P, and PRPP concentrations exhibited a less pronounced increase on glucose addition when respiration was inhibited. Antimycin-treated wild-type, *isn1*, and *pnp1* cells had a very similar metabolite profile in response to glucose addition, whereas that of the *amd1* mutant was significantly different. The increase in PRPP concentration was strongly delayed in the *amd1* mutant ([Figures 6](#f6){ref-type="fig"}, [8B](#f8){ref-type="fig"}, and [Supplementary Figures S3--S6](#S1){ref-type="supplementary-material"}). Furthermore, deletion of *AMD1* resulted in significant changes in the dynamics of glycolytic metabolite concentrations. In particular, G3P concentration increased two-fold higher than in the wild-type strain, and T6P levels decreased significantly slowly than in all other tested strains ([Figures 6](#f6){ref-type="fig"}, [8C](#f8){ref-type="fig"}, and [Supplementary Figures S3--S6](#S1){ref-type="supplementary-material"}). Finally, we observed that R1P only accumulated to significant concentrations when Pnp1 was functional, and inosine was converted into hypoxanthine ([Figure 6](#f6){ref-type="fig"}).

Phenotypic characterization of purine salvage pathway mutants
-------------------------------------------------------------

In search for potential functions of adenine nucleotide cycling, we asked whether mutants defective in this process exhibit differences to the wild-type behavior under constant or transient cultivation conditions. To answer this question, strains carrying mutations in the PSP were cultivated on minimal medium using trehalose as a non-fermentable, and glucose as a fermentable carbon source. As shown in [Figure 9A](#f9){ref-type="fig"}, the investigated mutants neither exhibited a growth phenotype under respiratory nor under fermentative growth conditions. Only the *adk1* mutant had a strongly decreased growth rate on glucose. This behavior has already been reported previously ([@b36]), and is consistent with the inability of this mutant to restore its ATP pool when exposed to glucose ([Figure 5V](#f5b){ref-type="fig"}). Furthermore, growth of the wild-type and *amd1* strains was compared under anaerobic conditions, but no differences could be observed (data not shown). Thus, we conclude that mutants with impaired adenine nucleotide cycling do not exhibit a growth phenotype under the constant cultivation conditions that we have tested.

We next asked whether inhibition of respiration and absence of AXP cycling in *amd*1, *isn1*, and *pnp1* mutant strains had an impact on the formation of fermentative end products and sugar consumption during the respiro-fermentative transition. During the first 20 min after glucose addition, wild-type cells produced ∼25% less glycerol and ethanol when antimycin A was absent ([Figure 9B](#f9){ref-type="fig"}). Thereafter, cultures without antimycin A produced ethanol and glycerol at higher rates identical to cultures exposed to antimycin A (data not shown). No differences with respect to glucose consumption, as well as ethanol and glycerol production could be detected between wild-type and the tested PSP mutants ([Figure 9B](#f9){ref-type="fig"}).

Furthermore, we monitored growth acceleration of the PSP mutants after glucose addition by assessing the budding index of the cell populations. As shown in [Figure 9C](#f9){ref-type="fig"}, the proportion of budded cells in the wild-type and *pnp1* cultures increased significantly already within the first 30 min after the pulse and remained constant after 45 min. In contrast, the increase of the budding index for the *amd1* and *isn1* strains exhibited a strong delay. During the first 30 min after glucose addition almost no new buds were formed by those strains, and wild-type levels of budded cells were only reached at around 60 min after glucose addition.

Discussion
==========

The purine salvage pathway is implicated in the control of AXP concentration during the respiro-fermentative growth transition
------------------------------------------------------------------------------------------------------------------------------

The purine salvage pathway facilitates the salvage and redistribution of purine bases and nucleotides, respectively, which are released on RNA degradation, or which are taken up from extracellular sources. In human, deficiency of enzymes of this pathway has been associated to pathologies, such as mental retardation and severe immunodeficiency ([@b57]; [@b14]). In this study, we extend this view showing that the PSP, at least in yeast, contributes to AXP homeostasis by facilitating the transient drainage of AXP nucleotides into IMP and inosine. The pathway for inosine formation and recycling, as well as the interplay between different pathways during the respiro-fermentative transition are schematically summarized in [Figure 10](#f10){ref-type="fig"}. The presence of a quickly metabolizable sugar causes accumulation of the phosphorylated metabolites F1,6P, T6P and G3P, which results in a transient imbalance of ATP-consuming and ATP-regenerating reactions, and provokes a drop in both ATP and intracellular phosphate (Pi) concentration. The joint action of fast ATP consumption and the Adk1 reaction results in the net-production of AMP. The accumulation of AMP, however, is prevented by Amd1 and Isn1, which readily convert AMP via IMP into inosine. Recycling of inosine into IMP is facilitated by Pnp1 and the concomitant action of Hpt1 and Xpt1, with Hpt1 having the predominant role.

Purine nucleotide (i.e. IMP) *de novo* synthesis seems to contribute significantly to the re-establishment of initial AXP levels, as witnessed by the incomplete recovery of adenine nucleotide levels in the *ade5,7* mutant. However, in this context it is important to note that the *ade5,7* strain was cultivated in the presence of adenine to complement its purine base auxotrophy. The presence of adenine is known to strongly repress the expression of genes implicated in purine nucleotide *de novo* synthesis ([@b26]), and may thus have also affected activities of enzymes involved in inosine recycling. Therefore, we consider it likely that wild-type cells are able to reconvert a larger fraction (if not all) of the inosine into AMP without implying *de novo* nucleotide synthesis. Our results also showed that the conversion of inosine into hypoxanthine by the Pnp1 reaction was the only significant source of R1P, as concentrations of this metabolite in the *amd1* and *isn1* mutants were almost undetectable. Whether the R1P released during the conversion of inosine to hypoxanthine is recycled into the pentose phosphate pathway, or is used in pyrimidine salvage reactions, as proposed by [@b66] remains an open question.

In contrast to the behavior observed in the presence of fermentable carbon sources, under respiratory conditions neither IMP nor inosine were formed in response to perturbations of the cellular energy balance. Instead, the drop in ATP level caused a concomitant increase in AMP concentration. Therefore, we conclude that the conversion of AXP nucleotides into inosine represents a specific short-term metabolic response to the perturbation of cellular energy homeostasis, which is controlled by the presence of a fermentable carbon source (or a sugar derivative that can undergo rapid phosphorylation). The discrimination between AMP accumulation and AMP-to-inosine conversion seems to be controlled by Amd1 activity. At the present stage of investigation, we cannot conclude whether regulation of Amd1 is brought about by allosteric control or by posttranslational modification. However, given that inorganic phosphate is a potent inhibitor of Amd1 ([@b48]) and intracellular phosphate concentration transiently drops when cells become exposed to fermentable carbon sources (our data, and e.g. [@b28]), phosphate availability is likely to have a pivotal role in the regulation of AXP pool size and inosine formation.

Under constant respiratory and fermentative cultivation conditions, the tested PSP mutant strains did not exhibit any growth phenotype. Furthermore, no altered accumulation of inosine or hypoxanthine was observed under these conditions in PSP mutant cells. We conclude that AXP cycling through inosine is restricted to transitory growth conditions in the presence of a fermentable carbon source, and is negligible during the tested constant respiratory or fermentative cultivation conditions. This idea is supported by a whole-genome metabolic network model of *S. cerevisiae*, which accounts for all PSP reactions found to be implicated in the control of AXP levels during the respiro-fermentative transition ([@b17]), and that predicts no flux across the reactions catalyzed by Amd1, Isn1, Pnp1 and Hpt1 during constant respiratory or fermentative growth ([@b15]).

Inhibition of respiration alters AXP level recovery
---------------------------------------------------

Our study revealed a strong impact of mitochondrial function on both rate and final level of ATP recovery. In the absence of the mitochondrial inhibitor, antimycin A, ATP concentration recovered to almost the same level as before glucose addition, whereas inhibition of respiration caused the ATP concentration to reach only ∼65% of its initial value. When mitochondrial ATP production is inhibited, glycolytic flux, that is, the rate of substrate level phosphorylation, has to be augmented to compensate for the lacking energy supply coming from respiration. As ATP is a potent inhibitor of several glycolytic enzymes ([@b59]), the decrease in ATP level derepresses glycolysis, thereby facilitating a higher fermentation rate to supply energy. Indeed, during the first 20 min after glucose addition we estimated ethanol and glycerol production rates that were ∼25% lower in the absence of the mitochondrial inhibitor antimycin A. This finding is in line with earlier studies that reported the coincidence of decreasing ATP concentrations on increased glycolytic flux ([@b40], [@b41]; [@b35]). We provide a refined description of this phenomenon by showing that the decrease of ATP under completely fermentative conditions does not cause augmentation of ADP nor AMP, but rather results in a decrease of the sum of all AXP nucleotides to ∼65% of its concentration under respiratory conditions.

Adenylic energy charge can serve as a measure of the fitness of a cell ([@b12]). The response of this measure to glucose addition with and without antimycin A was compared for different mutants. Our data showed that only in the *amd1* mutant kinetics of e-charge restoration depended on functional respiration. These results demonstrated that, in accordance with previous *in vitro* data ([@b77]), mutants defective in AMP deaminase were significantly more sensitive to inhibition of respiration than the wild-type and other PSP mutants.

Absence of AXP nucleotide cycling interferes with metabolic regulation
----------------------------------------------------------------------

The AXP-to-inosine conversion prevents unscheduled AMP accumulation during the respiro-fermentative growth transition. Adenosine monophosphate is a potent activator of phosphofructokinase ([@b4]; [@b53]). Furthermore, accumulation of AMP displaces the equilibrium of adenylate kinase toward higher ADP and lower ATP concentrations, respectively (see [Figures 5A](#f5a){ref-type="fig"} and [6](#f6){ref-type="fig"}, [Supplementary Figure S2D](#S1){ref-type="supplementary-material"}). The ATP/ADP ratio in turn controls activities of the glycolytic enzymes: hexokinase, phosphofructokinase, pyruvate kinase and phosphoglycerate kinase ([@b59]). Hence, accumulation of AMP can be expected to interfere with the regulation of the glycolytic pathway. Indeed, our results showed that the increase in AMP concentration in the *amd1* mutant provoked *trans*-acting effects in glycolytic metabolite levels, such as the hyper-accumulation of G3P, and delayed degradation of T6P after glucose addition. Changes in metabolite concentration indicate altered flux through adjacent metabolic reactions. However, they do not allow us to conclude whether these changes were caused by alterations in the production or consumption of the corresponding metabolite, nor do they permit to make conclusions on the duration of these alterations. However, variations in metabolite concentrations allow identifying cross-talk between different pathways, thereby guiding further research to potential hotspots of metabolic regulation. In the case of T6P, the concentration of the metabolite exerts a regulatory effect on glycolysis by inhibiting hexokinase and, thus, sugar influx ([@b64]). The persistence of a higher T6P concentration in the *amd1* mutant was not caused by alterations of the G6P level that was indistinguishable from the wild-type cells in the relevant time span. Therefore, a delayed T6P degradation in the *amd1* mutant points to the possibility that the accumulation of this glycolytic regulator is controlled by AMP and/or the ATP/ADP ratio.

Despite pronounced changes in metabolite pool dynamics caused by the deletion of *AMD1*, no alterations in the production of the fermentative end-products ethanol and glycerol, nor in the consumption of glucose were observed. We suggest that rearrangements of glycolytic metabolite levels in the *amd1* mutant, for example, the prolonged accumulation of the hexokinase inhibitor, T6P, may have compensated the effect of altered AXP ratios on glycolytic enzymes. This interpretation is supported by the fact that altering the activity of one or more glycolytic enzymes does not result in the change of overall flux across this pathway, but rather in changing glycolytic metabolite concentrations ([@b50]). Moreover, the observation of unaltered fermentation capacity in *amd1* points to the possibility that regulation of glycolysis is not the major target of AMP. Indeed, our study revealed a delayed increase in PRPP concentration in the *amd1* strain after glucose addition. PRPP has a central role as a precursor for purine nucleotide *de novo* synthesis and in the synthesis of amino acids ([@b69]). Hence, limitation of this important precursor may negatively affect growth. In bacteria and humans, PRPP synthase is inhibited by ADP and AMP but not by ATP ([@b18]; [@b1]; [@b73]). Our results indicated that AMP and/or ADP nucleotides interfere with PRPP-producing or -consuming reactions even in yeast, thereby supporting the idea of a regulatory link between purine nucleotide synthesis and energy homeostasis ([@b2]).

What is the function of AXP nucleotide cycling through the purine salvage pathway?
----------------------------------------------------------------------------------

Unscheduled AMP accumulation interferes with metabolic regulation during the respiro-fermentative growth transition. To prevent AMP-induced metabolic rearrangements, *S. cerevisiae* uses a system to convert this nucleotide into IMP and further into inosine. To the best of our knowledge, IMP and inosine do not interfere with glycolytic regulation. This idea is supported by the fact that no differences in metabolite pool dynamics after glucose addition were detected in the *isn1* and *pnp1* mutant strains when compared with the wild-type cells. We therefore suggest that inosine formation serves to prevent unscheduled AMP accumulation, and to store AXP nucleotides in a metabolically 'neutral\' form until re-equilibration of glycolysis eventually allows the recovery of ATP levels. Recycling of inosine through IMP represents an energy-saving way to replenish the AXP pool, as *de novo* synthesis of IMP starting from PRPP requires 4 ATP molecules, whereas IMP production from inosine and PRPP is an ATP-neutral process ([Figure 10](#f10){ref-type="fig"}).

However, on following this explanation, the role of Isn1, that is, the function of the conversion of IMP into inosine, remains somewhat enigmatic. Considering that high IMP concentrations that accumulate in the *isn1* strain will provide IMP dehydrogenase with elevated substrate levels, one might speculate that IMP-to-inosine conversion prevents a potentially catastrophic overflow of GXP nucleotides similar to what was found by [@b7]. However, neither GMP nor other GXP nucleotides were found to be increased after glucose addition in the *isn1* mutant. As the *isn1* strain exhibited no deviations from the wild-type behavior with respect to the monitored 24 metabolite concentrations, one may thus ask why the yeast uses this additional step. A potential explanation might lie in the regulation of the Pnp1 reaction that controls the recycling of inosine: the thermodynamic equilibrium of this reaction actually favors the production of inosine from hypoxanthine ([@b8]). Only high concentrations of phosphate, which are normally present in live cells displace the equilibrium toward the production of hypoxanthine. This subtle regulation makes Pnp1 the ideal candidate to control the recycling of inosine into AXP nucleotides once increasing phosphate concentrations indicate re-equilibration of glycolysis. Indeed, inosine recycling coincided with the increase in intracellular phosphate concentration (compare [Figures 1D](#f1){ref-type="fig"} and [2B](#f2){ref-type="fig"}).

Besides the discussed direct effects on metabolic regulation, unscheduled AMP accumulation may also have an important impact on signaling pathways. The cAMP/PKA signaling pathway has the predominant role in the control of the respiro-fermentative growth transition ([@b63]; [@b78]). The formation of cAMP by adenylate cyclase, Cyr1, is ATP dependent ([@b33]) and may be affected by changes in the AXP balance. However, to the best of our knowledge, no data exist that demonstrate a direct impact of AMP concentration or the ATP/ADP ratio on cAMP formation and/or PKA activation. In mammals, the AMP-activated protein kinase (AMPK) controls a large number of metabolic pathways and serves to ensure energy homeostasis of the cells (for review, see [@b27])). The *S. cerevisiae* AMPK homolog, Snf1, was shown to be indispensable for the transcription of glucose-repressed genes ([@b10]), and unscheduled activation of this kinase by elevated AMP levels might negatively affect the transition to fermentative growth. However, in contrast to the mammalian AMPK, the yeast homolog, Snf1, could not be shown to be directly activated by AMP, although its instantaneous activation was demonstrated under conditions in which AMP levels increased ([@b74]). Thus, the assumption of a signaling role of AMP through the cAMP/PKA cascade or Snf1 in yeast remains speculative, although intriguing, when asking for the actual function of AXP-to-inosine conversion during the respiro-fermentative transition.

Concluding remarks
------------------

On the basis of this study, we put forward the implication of adenine nucleotide cycling through the PSP in energy homeostasis in yeast. Although it was earlier proposed that Amd1 facilitates regulation of AXP levels in response to changes in the adenylic energy charge ([@b11]; [@b76]), our results extend this view by demonstrating that, at least in yeast, the IMP formed by the action of Amd1 is further converted into inosine. Answering the question whether this pathway is also active in humans could potentially contribute to a better understanding of metabolic processes that control the metabolic transition from respiratory to respiro-fermentative energy supply in muscle on heavy exercise. In particular, it may help to understand conflicting results on the impaired physical performance of individuals carrying an AMP deaminase dysfunction under these conditions ([@b58]; [@b16]).

Materials and methods
=====================

Strains and cultivation conditions
----------------------------------

All strains used in this study were derived from the strain BY4741 *Mat* **a** *ura3 met1 his3 leu2* background (referred to as wild type). Single deletion mutants were taken from the EUROSCARF collection ([@b6]). The BY *hpt1--xpt1* double mutant was obtained by crossing and sporulating the corresponding single deletion mutants, and identifying double knockouts in the segregant population by PCR.

Glucose-limited growth was mimicked by growing the strains in a medium containing 10 g/l trehalose (Sigma), 5 g/l (NH~4~)~2~SO~4~, 1.76 g/l YNB (yeast nitrogen base without amino acids and ammonium sulfate; Difco), as well as amino-acid supplements at a final concentration of 100 mg/l to complement the auxotrophies of the strains. The medium was buffered at pH 4.8 by adding 14.6 g/l succinic acid and 6 g/l NaOH ([@b30]). Cells were cultivated in Erlenmeyer flasks at 30°C, and shaken on a rotary shaker (Infors) at 200 r.p.m. When yeast cultures reached a biomass concentration of 1 g/l, glucose was added at a final concentration of 20 g/l from a concentrated stock solution of 400 g/l. To block mitochondrial function, antimycin A (0.4 mg/ml dissolved in ethanol) was added at a final concentration of 2 μg/ml 1.5 min before glucose. Block of respiratory activity by the adjusted antimycin A concentration was confirmed by the inability of the cells to grow on the non-fermentable carbon sources: trehalose and glycerol (data not shown).

Metabolite sampling and analysis
--------------------------------

Sampling for intracellular metabolites was carried out by filtering 5 ml of culture medium on a polyamide membrane (pore size 0.45 μm, Sartorius) and quenching the metabolism of cells in 80°C hot buffered ethanol (HEPES 10 mM, 75% ethanol, pH 7.1). Processing of the samples and metabolite quantification by high-performance ionic chromatography was done as described previously ([@b22]; [@b44]).

Samples of glucose pulses on wild-type (with and without antimycin A), *amd1*, *isn1*, and *pnp1* mutant strains (all in the presence of antimycin A) were additionally analyzed by LC-MS spectrometry according to the following procedures. High performance liquid anion exchange chromatography: liquid anion exchange chromatography was performed on an ICS 2000 system from Dionex (Sunnyvale, CA, USA) equipped with an eluent generator system (EG 50, Dionex) for automatic base generation (KOH). Analytes were separated by anion exchange chromatography on an IonPac AS11 (250 × 2 mm, Dionex) column equipped with an AG11 (50 × 4 mm, Dionex) pre-column at a flow rate of 0.35 ml/min. Column temperature was 22°C. Metabolite separation was based on a previously described method ([@b24]). Eluent was a gradient of KOH carried out as follows: 0 min 0.5; 13 min, 4.1; 20 min, 4.1; 30 min, 10; 45 min, 20; 60 min: 40, 65 min, 40; 65 min, 0.5; and 70 min, 0.5. Gradients were always linear. In all cases the injected sample volume was 15 μl. For background reduction, an AMMS 2-mm chemical suppressor from Dionex was used. The reagent flow (25 mM H~2~SO~4~) was set to 3 ml/min. Mass spectrometry: tandem mass analyses were carried out with a 4000 Q Trap triple mass spectrometer (Applied Biosystems, Foster City, CA, USA) with Turbo V source MDS Sciex (Toronto, Canada) for electro spray ionization. Fragmentation was done by collision-activated dissociation using nitrogen as collision gas at moderate pressure. The ion chromatograph was coupled to the mass spectrometer without splitting. The nebulizer gas pressure was 40 psi, the desolvation gas pressure was 50 psi, the desolvation gas temperature was 650°C and the capillary voltage was −3.3 kV. The MS/MS analysis has been performed as described previously ([@b34]).

Glucose consumption and glycerol and ethanol productions were followed over 60 min after glucose addition. Glucose consumption was estimated by a glucose peroxidase-based enzymatic assay (Sigma). Ethanol and glycerol productions were estimated using enzymatic assays (Boehringer Mannheim).

Analysis of budding index
-------------------------

To monitor changes in the budding index of the populations, cells were fixed in 80% ethanol and kept at 4°C until further analysis. To prepare cells for counting, they were washed once with distilled water, resuspended in 1 ml water containing 5 μl of Tween80, and sonicated (Bioblock Scientific, Vibra Cell 72412) for 10 s at 20% intensity. At least 600 cells from two independent experiments were counted per time point.
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![Intracellular concentrations of glycolytic, TCA cycle, and pentose phosphate pathway metabolites after exposure of trehalose-grown wild-type cells to sudden increase of glucose concentration to 110 mmol/l. (**A**) ATP, ADP, and AMP; (**B**) GTP, GDP, and GMP; (**C**) sum of adenine and guanine nucleotides; (**D**) energy charge, inorganic phosphate (Pi); (**E**) glycerol-3-phosphate (G3P); trehalose-6-phosphate (T6P); (**F**) glucose-6-phosphate (G6P); glucose-1-phosphate (G1P); (**G**) malate; (**H**) ribose-5-phosphate (R5P); ribose-1-phosphate (R1P); (**I**) fructose-6-phosphate (F6P); fructose-1,6-bisphosphate (F1,6P); (**J**) 6-phosphogluconate (6PG); phosphoribosyl pyrophosphate (PRPP); (**K**) alpha-ketoglutarate (alphaKG); (**L**) phosphoenolpyruvate (PEP); pooled 2 and 3-phosphoglycerate (2/3PG); 1,3-phosphodiglycerate (1,3diPG). Data shown represent the average of at least two independent experiments. Metabolite concentrations are provided in tabular form in [Supplementary information II](#S1){ref-type="supplementary-material"}.](msb2009100-f1){#f1}

![Intracellular concentrations of adenine nucleotides and selected purine salvage pathway metabolites after exposure of trehalose-grown wild-type cells to sudden increase of glucose concentration to 110 mmol/l. (**A**) ATP, ADP, and AMP; (**B**) hypoxanthine, inosine, IMP; (**C**) sum of AXP nucleotides, sum of (AXP+IMP+inosine+hypoxanthine). Data represent the average of at least two independent experiments.](msb2009100-f2){#f2}

![Intracellular concentrations of adenine nucleotides and selected purine salvage pathway metabolites in response to addition of sugar derivatives and different perturbations of energy homeostasis under fermentative and respiratory conditions. Addition of (**A**--**C**) 6-deoxyglucose, (**D**--**F**) 2-deoxyglucose (each at a final concentration of 110 mmol/l) to trehalose-grown cells. Addition of H~2~O~2~ (final concentration 2 mM) to (**G**--**I**) glucose-grown or (**J**--**L**) trehalose-grown cells. (**M**--**O**) Addition of antimycin A (final concentration 2 μg/ml) to trehalose-grown cells. (**P**--**R**) Transfer of glucose-grown cells to medium containing 110 mmol/l trehalose as the only carbon source. Cells were cultivated on glucose until mid-exponential phase, spun down by centrifugation, and resuspended in trehalose medium having the same composition except for the carbon source. (Cells that were resuspended in glucose medium as a control did not exhibit any change in AXP concentration; data not shown.) All experiments were carried out using wild-type cells. Left panel of figures: ATP, ADP, and AMP. Middle panel of figures: hypoxanthine, inosine, and IMP. Right panel of figures: Sum of AXP nucleotides, sum of (AXP+IMP+inosine+hypoxanthine). Data represent the average of at least two independent experiments.](msb2009100-f3){#f3}

![Schematic representation of purine salvage pathway reactions. Metabolites are depicted in black and enzymes in blue. Dashed lines with question marks indicate reactions that exist according to the KEGG database but which were not yet identified in *Saccharomyces cerevisiae*. (Metabolites: AdeS, adenylosuccinate; Asp, aspartate; Fum, fumarate; PRPP, phosphoribosyl pyrophosphate; PP~i~, pyrophosphate; P~i~, phosphate. Enzymes: Aah1, adenine deaminase; Ade5,7, aminoimidazole ribotide synthetase and glycinamide ribotide synthetase; Ade13, adenylosuccinate lyase; Ade12, adenylosuccinate synthase; Adk1, adenylate kinase; Ado1, adenosine kinase; Amd1, AMP deaminase; Apt1, adenine phosphoribosyltransferase; Gua1, GMP synthase; Gud1, guanine deaminase; Guk1, guanylate kinase; Hpt1, hypoxanthine--guanine phosphoribosyltransferase; Imd2,3,4, IMP dehydrogenase; Isn1, IMP-specific 5′-nucleotidase; Pnp1, purine nucleoside phosphorylase; Xpt1, xanthine--guanine phosphoribosyltransferase; Ynk1, nucleoside diphosphate kinase; adapted from [@b42]), the KEGG database ([@b32]), and personal communication from Drs B Daignan-Fornier and B Pinson.](msb2009100-f4){#f4}

![Intracellular concentrations of adenine nucleotides and selected purine salvage pathway metabolites after exposure of trehalose-grown purine salvage pathway mutants to sudden increase of glucose concentration to 110 mmol/l. Data corresponding to each mutant are arranged row wise. Left panel of figures: ATP, ADP, and AMP. Middle panel of figures: hypoxanthine, inosine, and IMP. Right panel of figures: Sum of AXP nucleotides, sum of (AXP+IMP+inosine+hypoxanthine). Data represent the average of at least two independent experiments. Metabolite concentrations are provided in tabular form in [Supplementary information I](#S1){ref-type="supplementary-material"}.](msb2009100-f5a){#f5a}

![Continued.](msb2009100-f5b){#f5b}

![Intracellular metabolite concentrations in trehalose-grown wild-type, *amd1*, *isn1*, and *pnp1* mutant strains after a sudden increase in glucose concentration to 110 mmol/l in the presence of 2 μg/ml antimycin A. Antimycin A was added 1.5 min before glucose. The left panel shows intracellular concentrations for the WT strain in the absence of antimycin A as a reference. Metabolite concentrations were normalized to the highest concentration measured in all mutants over all time points. Actual concentrations corresponding to maximum and minimum values are shown on the right of the figure. Data represent the average of at least two independent experiments. Metabolite concentrations are provided in tabular form in [Supplementary information II](#S1){ref-type="supplementary-material"}.](msb2009100-f6){#f6}

![Time course of energy charge in trehalose-grown (**A**) wild-type, (**B**) *amd1*, (**C**) *isn1*, and (**D**) *pnp1* mutant strains after sudden increase in glucose concentration to 110 mmol/l in the presence or absence of 2 μg/ml antimycin A. Antimycin A was added 1.5 min before glucose. Data represent the average of at least two independent experiments.](msb2009100-f7){#f7}

![Intracellular metabolite concentrations in trehalose-grown wild-type and *amd1* mutant strain after a sudden increase of glucose concentration to 110 mmol/l in the presence and absence of 2 μg/ml antimycin A. Antimycin A was added 1.5 min before glucose. (**A**) adenine nucleotides (AXP); (**B**) phosphoribosyl pyrophosphate (PRPP); (**C**) trehalose-6-phosphate (T6P); (**D**) glycerol-3-phosphate (G3P). Data represent the average of at least two independent experiments.](msb2009100-f8){#f8}

![(**A**) Growth rates of mutants implicated in purine nucleotide cycling on glucose or trehalose as the limiting carbon source. Growth rates were measured in shake flask experiments at 30°C with initial concentrations of 20 g/l carbon source. Data represent the average of at least 3 independent experiments. (**B**) Glucose consumption, ethanol and glycerol production rates, respectively, in wild-type *amd1*, *isn1*, and *pnp1* mutant strains after a sudden increase of glucose concentration to 22 mmol/l. Antimycin A was added at 2 μg/ml unless otherwise stated. (**C**) Budding index of trehalose-grown wild-type, *amd1*, *isn1*, and *pnp1* mutant strains after a sudden increase of glucose concentration to 110 mmol/l in the presence of 2 μg/ml antimycin A. Antimycin A was added 1.5 min before glucose. Data represent the average of at least two independent experiments from which at least 600 cells were counted for each time point. The differences in budding index of the different strains were statistically analyzed for the time point at 30 min after glucose addition. (^\*^) The budding index of wild-type and *pnp1* mutant was significantly higher than for the *amd1* and *isn*1 mutants with a confidence level of *P*=0.013. Measured values are provided in tabular form in [Supplementary information III](#S1){ref-type="supplementary-material"}.](msb2009100-f9){#f9}

![Schematic representation of pathways implicated in purine nucleotide cycling. Metabolites are depicted in black and enzymes in blue.](msb2009100-f10){#f10}

###### Accumulation of inosine in response to exposure of trehalose-grown wild-type cells to different nutrients and sugar derivatives

  Condition                  Concentration \[μmol/g DW\]                         
  -------------------------- ----------------------------- ---------- ---------- ----------
  Trehalose medium^a^        3.7±0.50                          0      5.7±0.56   5.7±0.56
  20 g/l Glucose^b^          2.4±0.26                       1.8±0.4   3.9±0.56   5.7±0.30
  20 g/l Fructose^b^         1.8±0.31                       2.5±0.4   3.5±0.26   5.9±0.30
  20 g/l Mannose^b^          1.8±0.33                       2.4±0.4   3.1±0.34   5.5±0.30
  100 g/l Ethanol^b^         3.5±0.25                          0      5.6±0.36   5.6±0.36
  20 g/l 6-Deoxyglucose^b^   3.9±0.18                          0      5.5±0.20   5.5±0.40
  20 g/l 2-Deoxyglucose^b^   0.6±0.15                       4.1±0.33  1.8±0.10   5.9±0.26

[^1]: Present address: UMR-INRA Sciences pour l\'Oenologie 2, place Viala, 34060 Montpellier Cedex, France
